Ophthalmic antiviral chemotherapy: an overview.

Simple item page
dc.contributor.authorAthmanathan, Sen_US
dc.contributor.authorGarg, Pen_US
dc.contributor.authorRao, G Nen_US
dc.date.accessioned1997-12-06en_US
dc.date.accessioned2009-05-29T07:44:00Z
dc.date.available1997-12-06en_US
dc.date.available2009-05-29T07:44:00Z
dc.date.issued1997-12-06en_US
dc.description34 references.en_US
dc.description.abstractAntiviral drug development has been slow due to many factors. One such factor is the difficulty to block the viral replication in the cell without adversely affecting the host cell metabolic activity. Most of the antiviral compounds are analogs of purines and pyramidines. Currently available antiviral drugs mainly inhibit viral nucleic acid synthesis, hence act only on actively replicating viruses. This article presents an overview of some of the commonly used antiviral agents in clinical ophthalmology.en_US
dc.description.affiliationDevchand Nagardas Jhaveri Microbiology Centre, L.V. Prasad Eye Institute, Hyderabad, India. sreedhar@lvpeye.stph.neten_US
dc.identifier.citationAthmanathan S, Garg P, Rao GN. Ophthalmic antiviral chemotherapy: an overview. Indian Journal of Ophthalmology. 1997 Dec; 45(4): 203-10en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/69680
dc.language.isoengen_US
dc.source.urihttps://www.ijo.inen_US
dc.subject.meshAntiviral Agents --adverse effectsen_US
dc.subject.meshDNA Replication --drug effectsen_US
dc.subject.meshDNA, Viral --drug effectsen_US
dc.subject.meshEye Infections, Viral --drug therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshVirus Physiological Phenomenaen_US
dc.subject.meshVirus Replication --drug effectsen_US
dc.titleOphthalmic antiviral chemotherapy: an overview.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Ophthalmology